Tellgen Corporation

¥16.02As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300642Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.93%)
Div yield 0.31%
ROE 1.08%
Medical Devices
Beta (5Y) 0.47
PE TTM 137.7
TSR TTM (32.85%)
Mkt cap ¥2.557B
ROIC 1.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
(3.79%)
(38.90%)
Hold 7|3|8|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.27
0.30
0.33
0.36
36.56%
43.12%
40.82%
41.75%
Revenue¥M
234.4
232.3
239.4
244.9
10.62%
7.60%
6.58%
7.51%
Peers (US$383.2M)
Cap (US$)
PE
380.5M
39.84x
394.2M
5.188x
Capital
TTM
5Y
10Y
Leveragex
12.11
0.019
0.020
EBIT/Intx
0.103
0.097
0.091
Own earn%
60.81
128.10
103.60
Sh yield%
43.77
24.51
21.75
Owners
Insiders/Inst%
13.87
63.84
Short interest%
3.99
SBC / revenue%
0.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
9–18
$1 testx
—
Incr. ROIC%
9